The null hypothesis will be that the probability of reduced coverage
of the recurrence volume by the radiotherapy plan based on a CTV_aMRI,
is more than or equal to 0.20. With a sample size of 48 patients whom
have developed tumor recurrence, an exact binomial test with a
one-sided significance level (alpha) of 0.025 will have 90% power to
reject the null hypothesis if the true probability is 0.050.




METC 3: “an exact binomial test with a one-sided significance level
(alpha) of 0.025 will have 90% power to reject the null hypothesis if
the true probability is 0.050.” Graag deze true probability
onderbouwen (literatuur/pilot data).

Wij verwachten dat er heleaal geen verschil zal zijn, dwz dat de true
probability 0% is.  Voor de berekeing zijn we uitgegaan van 5% als
iets pessimistischer scenario.
